402 related articles for article (PubMed ID: 26807761)
61. Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer.
Stewart DA; Cooper CR; Sikes RA
Reprod Biol Endocrinol; 2004 Jan; 2():2. PubMed ID: 14711377
[TBL] [Abstract][Full Text] [Related]
62. Mechanisms involved in the metastasis of cancer to bone.
Orr FW; Kostenuik P; Sanchez-Sweatman OH; Singh G
Breast Cancer Res Treat; 1993; 25(2):151-63. PubMed ID: 8347847
[TBL] [Abstract][Full Text] [Related]
63. Cause and effect of microenvironmental acidosis on bone metastases.
Avnet S; Di Pompo G; Lemma S; Baldini N
Cancer Metastasis Rev; 2019 Jun; 38(1-2):133-147. PubMed ID: 30825056
[TBL] [Abstract][Full Text] [Related]
64. Mechanisms, Diagnosis and Treatment of Bone Metastases.
Ban J; Fock V; Aryee DNT; Kovar H
Cells; 2021 Oct; 10(11):. PubMed ID: 34831167
[TBL] [Abstract][Full Text] [Related]
65. Matricellular proteins in atherosclerosis development.
Pervaiz N; Kathuria I; Aithabathula RV; Singla B
Matrix Biol; 2023 Jun; 120():1-23. PubMed ID: 37086928
[TBL] [Abstract][Full Text] [Related]
66. Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression.
González-González L; Alonso J
Front Oncol; 2018; 8():225. PubMed ID: 29946533
[TBL] [Abstract][Full Text] [Related]
67. Role of the bone microenvironment in bone metastasis of malignant tumors - therapeutic implications.
Ma X; Yu J
Cell Oncol (Dordr); 2020 Oct; 43(5):751-761. PubMed ID: 32623700
[TBL] [Abstract][Full Text] [Related]
68. The multifaceted role of Matricellular Proteins in health and cancer, as biomarkers and therapeutic targets.
Gopinath P; Natarajan A; Sathyanarayanan A; Veluswami S; Gopisetty G
Gene; 2022 Mar; 815():146137. PubMed ID: 35007686
[TBL] [Abstract][Full Text] [Related]
69. Pathophysiologic interactions in skeletal metastasis.
Orr FW; Lee J; Duivenvoorden WC; Singh G
Cancer; 2000 Jun; 88(12 Suppl):2912-8. PubMed ID: 10898334
[TBL] [Abstract][Full Text] [Related]
70. Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion.
Grahovac J; Wells A
Lab Invest; 2014 Jan; 94(1):31-40. PubMed ID: 24247562
[TBL] [Abstract][Full Text] [Related]
71. Regulation of dormancy during tumor dissemination: the role of the ECM.
Mukherjee A; Bravo-Cordero JJ
Cancer Metastasis Rev; 2023 Mar; 42(1):99-112. PubMed ID: 36802311
[TBL] [Abstract][Full Text] [Related]
72. Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis.
Jiang D; Lim SY
Cancer Microenviron; 2016 Apr; 9(1):45-61. PubMed ID: 26956475
[TBL] [Abstract][Full Text] [Related]
73. Integrins in bone metastasis formation and potential therapeutic implications.
Clëzardin P
Curr Cancer Drug Targets; 2009 Nov; 9(7):801-6. PubMed ID: 20025568
[TBL] [Abstract][Full Text] [Related]
74. Role of extra cellular proteins in gastric cancer progression and metastasis: an update.
Abbaszadegan MR; Mojarrad M; Moghbeli M
Genes Environ; 2020; 42():18. PubMed ID: 32467737
[TBL] [Abstract][Full Text] [Related]
75. SPARCL1 a novel player in cancer biology.
Gagliardi F; Narayanan A; Mortini P
Crit Rev Oncol Hematol; 2017 Jan; 109():63-68. PubMed ID: 28010899
[TBL] [Abstract][Full Text] [Related]
76. Evolving cancer-niche interactions and therapeutic targets during bone metastasis.
Satcher RL; Zhang XH
Nat Rev Cancer; 2022 Feb; 22(2):85-101. PubMed ID: 34611349
[TBL] [Abstract][Full Text] [Related]
77. Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer.
Supuramanian SS; Dsa S; Harihar S
Explor Target Antitumor Ther; 2023; 4(5):912-932. PubMed ID: 37970212
[TBL] [Abstract][Full Text] [Related]
78. Transcriptomic Response to Acidosis Reveals Its Contribution to Bone Metastasis in Breast Cancer Cells.
Yamagata AS; Freire PP; Jones Villarinho N; Teles RHG; Francisco KJM; Jaeger RG; Freitas VM
Cells; 2022 Feb; 11(3):. PubMed ID: 35159353
[TBL] [Abstract][Full Text] [Related]
79. Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.
Sawyer AJ; Kyriakides TR
Adv Drug Deliv Rev; 2016 Feb; 97():56-68. PubMed ID: 26763408
[TBL] [Abstract][Full Text] [Related]
80. Metastatic bone disease: pathogenesis and new strategies for treatment.
Uchida A; Wakabayashi H; Okuyama N; Okamura A; Matsumine A; Kusuzaki K
J Orthop Sci; 2004; 9(4):415-20. PubMed ID: 15278783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
